Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags GSK plc AstraZeneca PLC Health & Science
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Tags Earnings Business News Biotechnology
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Coca/Cola Co Biogen Inc Business News
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Earnings Business News Biotechnology
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Caterpillar Inc Investing KB Home
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Reddit Inc Comcast Corp Uber Technologies Inc
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags Biogen Inc PRO: Playbooks Lockheed Martin Corp
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Rivian Automotive Inc General Motors Co
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Business Health & Science Science
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Biogen Inc Breaking News: Earnings Breaking news
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Health & Science Business Breaking news
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags US: News Biogen Inc Breaking News: Business
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Health care industry Eisai Co Ltd Pharmaceuticals
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Investment Strategy Investment strategy Stock Picks
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Business Kratos Defense and Security Solutions Inc stocks
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags Earnings Business News Biotechnology
From CNBC.com News
5 things to know before the stock market opens Monday
Tags JetBlue Airways Corp Meta Platforms Inc Merck & Co Inc
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Business Eli Lilly and Co Health & Science
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Eisai Co Ltd Health care industry Health & Science
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Lyft Inc Politics Economy
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Business Social issues Health & Science
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Amgen Inc Companies Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy 5 Things to Know Economy
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Health & Science Business Science
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Enphase Energy Inc Reata Pharmaceuticals Inc Mondelez International Inc
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags United Parcel Service Inc Markets Stock markets
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.